Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry
|
November 11, 2008
C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors
Roger Hunter, Yassir Younis, Clare I Muhanji, et al.
Journal of Medicinal Chemistry
|
October 9, 2007
From docking false-positive to active anti-HIV agent
Gabriela Barreiro, Joseph T Kim, Cristiano R W Guimarães, et al.
Leukemia
|
June 2, 2026
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors
Aditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2025
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors
Aditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.
Journal of the American Chemical Society
|
July 1, 2008
Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations
Jacob G Zeevaart, Ligong Wang, Vinay V Thakur, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2007
Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine
Hirotomo Nakata, Masayuki Amano, Yasuhiro Koh, et al.
Cancer Research Communications
|
January 29, 2024
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2006
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination
Toru Tobe, Scott A Beatson, Hisaaki Taniguchi, et al.
Molecular Cancer Therapeutics
|
February 11, 2021
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa, Prerna Singh, Christopher M Bailey, et al.
Journal of Medicinal Chemistry
|
May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy
Christopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry
|
November 11, 2008
C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors
Roger Hunter, Yassir Younis, Clare I Muhanji, et al.
Journal of Medicinal Chemistry
|
October 9, 2007
From docking false-positive to active anti-HIV agent
Gabriela Barreiro, Joseph T Kim, Cristiano R W Guimarães, et al.
Leukemia
|
June 2, 2026
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors
Aditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2025
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors
Aditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.
Journal of the American Chemical Society
|
July 1, 2008
Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations
Jacob G Zeevaart, Ligong Wang, Vinay V Thakur, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2007
Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine
Hirotomo Nakata, Masayuki Amano, Yasuhiro Koh, et al.
Cancer Research Communications
|
January 29, 2024
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2006
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination
Toru Tobe, Scott A Beatson, Hisaaki Taniguchi, et al.
Molecular Cancer Therapeutics
|
February 11, 2021
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa, Prerna Singh, Christopher M Bailey, et al.
Journal of Medicinal Chemistry
|
May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy
Christopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
Page
of 5